InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Goodwin Bradford S, Director. Director active across 2 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 2 reports have been published. The latest transaction was disclosed on 19 May 2021 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
025,000 shares0
Common Stock
SEC:0001179110-21-005771·
025,000 shares0
Common Stock
SEC:0001179110-21-005771:0·
2 of 2 declarations
About Goodwin Bradford S
Bradford S. Goodwin is a Board Member at Rigel Pharmaceuticals Inc. He plays a key role in the governance of the company, contributing to the definition of its strategy and guiding its research efforts. His experience in the biopharmaceutical sector is valuable in guiding Rigel in its development initiatives.
